Back

Pfizer Signs Up to $2.1 Billion Deal for Chinese Obesity Pill Development

The pharmaceutical giant expands its obesity treatment portfolio through a partnership with a Chinese company to co-develop an anti-obesity pill.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Obesity treatment: Medical interventions designed to aid weight loss and manage obesity-related health conditions.
  • Pharmaceutical partnership: An agreement between companies to jointly develop or market medical products.